ImmunoCellular management update

ImmunoCellular Therapeutics Ltd. (NYSE-M:IMUC), Woodland Hills, Calif. Business: Cancer Transitioned: John Yu to interim CEO and president, while remaining CSO and chairman; he succeeds Manish Singh, ...